New data intensify the agony over ecstasy.
D015104:3,4-Methylenedioxyamphetamine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000633:toxicity; D000662:Amphetamines / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D001921:Brain / Q000473:pathology; D000882:Haplorhini; D006801:Humans; D007880:Legislation, Drug; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D011613:Psychotherapy; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D019966:Substance-Related Disorders
D000662:Amphetamines; D012701:Serotonin; D015104:3,4-Methylenedioxyamphetamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine